Document Detail


Population pharmacokinetics of R- and S-carvedilol in Japanese patients with chronic heart failure.
MedLine Citation:
PMID:  20686235     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Carvedilol is a beta-adrenoceptor antagonist used for treating chronic heart failure (CHF). Two clinical studies were conducted to evaluate the population pharmacokinetics and pharmacodynamics of R- and S-carvedilol, and associated covariates, in patients with CHF. Fifty-eight patients (male=45, female=13) with New York Heart Association class I-IV CHF were enrolled in two clinical studies. R- and S-carvedilol concentrations were measured using HPLC at steady-state after oral administration of carvedilol at 1.25-20 mg o.d. or b.i.d. The data from both studies were used to estimate the population pharmacokinetic parameters and covariates using the nonlinear mixed effects model program. For 40 patients evaluated in one clinical study, the cytochrome P450 (CYP)2D6 *1, *10, and *5 genotypes were determined using allele-specific primer PCR, and individual patients' oral clearance (CL/F) of both enantiomers were estimated by the empirical Bayes method. A one-compartment model with a first-order absorption rate was established, in which body weight and alpha(1)-acid glycoprotein were significant covariates. Individual CL/F values for carvedilol were significantly lower in Japanese CHF patients with the CYP2D6 *1/*5, *5/*10 and *10/*10 genotypes. Estimation of the population pharmacokinetic parameters and their covariates for each enantiomer in Japanese patients with CHF showed that the CL/F values for R- and S-carvedilol were dependent on body weight, alpha(1)-acid glycoprotein, and CYP2D6 genotype. Prediction of exposure to free plasma carvedilol is important for dosage adjustment of beta-blocker therapy in patients with CHF.
Authors:
Masako Saito; Junichi Kawana; Tetsuro Ohno; Kazuhiko Hanada; Masahiro Kaneko; Kiyoshi Mihara; Mari Shiomi; Masatoshi Nagayama; Tetsuya Sumiyoshi; Hiroyasu Ogata
Related Documents :
14524595 - Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantatio...
16216975 - Effects of heat stress on thermoregulatory responses in congestive heart failure patients.
11401115 - Failure of aldosterone suppression despite angiotensin-converting enzyme (ace) inhibito...
16121765 - Concor, an initiative towards a national registry and dna-bank of patients with congeni...
14719425 - Severe cardiac failure associated with presumed jellyfish sting. irukandji syndrome?
9593345 - Clinicopathologic heterogeneity in hypertrophic cardiomyopathy with regard to age, asym...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biological & pharmaceutical bulletin     Volume:  33     ISSN:  1347-5215     ISO Abbreviation:  Biol. Pharm. Bull.     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-05     Completed Date:  2010-12-14     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  9311984     Medline TA:  Biol Pharm Bull     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1378-84     Citation Subset:  IM    
Affiliation:
Department of Biopharmaceutics, Meiji Pharmaceutical University, Kiyose, Tokyo 204-8588, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adrenergic beta-Antagonists / adverse effects,  blood,  pharmacokinetics*,  therapeutic use
Adult
Aged
Aged, 80 and over
Bayes Theorem
Carbazoles / adverse effects,  blood,  pharmacokinetics*,  therapeutic use
Chronic Disease
Cytochrome P-450 CYP2D6 / genetics
Female
Gene Frequency
Genetics, Population
Genotype
Heart Failure / blood,  drug therapy*,  enzymology
Humans
Japan
Male
Metabolic Clearance Rate
Middle Aged
Propanolamines / adverse effects,  blood,  pharmacokinetics*,  therapeutic use
Stereoisomerism
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0K47UL67F2/carvedilol; EC 1.14.14.1/Cytochrome P-450 CYP2D6

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin.
Next Document:  Glycemic index and glucose utilization of rice vermicelli in healthy subjects.